At Ohio Gastro, we improve the health of our patients through the delivery of high-quality care.
Established in 1996, Ohio Gastroenterology Group, Inc. is the leading provider of gastroenterology care and endoscopy procedures in central Ohio and surrounding regions.
We own and operate multiple clinical offices and state-of-the-art ambulatory surgery centers throughout the greater Columbus area. Our talented team includes physicians, anesthesia, nurses, and advanced practice providers, as well as over 300 clinical support, operations, and administrative staff members.
We perform more general and advanced endoscopy procedures each year than any other provider group in central Ohio, with the goal of delivering safe, personalized and comfortable care to help our patients enjoy healthier lives.
QUALITY PERFORMANCE REPORT
2022 Performance Results
The physicians at Ohio Gastroenterology Group, Inc. participate in GIQuIC, the GI Quality Improvement Consortium, a medical registry utilized by gastroenterologists in the United States. Physicians contribute procedure data to GIQuIC which is then analyzed so adjustments can be made to allow us to continuously improve the quality of care we provide to our patients. The data in GIQuIC is also used to advance research and develop guidelines for care across the field of gastroenterology.
GIQuIC is a powerful tool in the fight against colon cancer and we use it to look at a number of different measures to ensure our procedures are as thorough and effective as possible. Below are measures we track against the national goals that have been set by the GI societies.
Cecal Intubation Rate
The goal of a colonoscopy is to advance the scope all the way to the cecum and that is measured by Cecal Intubation Rate. The national standard for doing so has been set at 90% by the GI societies.
Adenoma Detection Rate
Adenoma Detection Rate, or ADR, is considered to be the most important quality indicator for a gastroenterologist and it calculates the percentage of time that at least one adenoma is detected during a colonoscopy. In fact, for every 1% increase in ADR, colorectal cancer rates decreased by 3% and morbidity decreases by 5%. The GI societies have set a national goal of 25% for Adenoma Detection Rate in screening colonoscopies.